Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Kin Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Kin Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 286 · Grade C

Kin Meds

Visit Kin Meds Full brief →

FDA warning letter, February 2026 — issued to Kin Meds. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Kin Meds a bad call — it's best for readers who can compare the separate brand-name pharmacy bill with a quote for compounded care. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
78
Transparency
90
72
Access Breadth
93
62
Clinical Oversight
92
74
Track Record
88
51
CoreAge RxBrief Score 94 · 64Kin Meds

Price, coverage & the tracker

CoreAge RxKin Meds
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Compounded injection from $199. Brand-name care advertises a $149/mo consultation, with medication billed separately.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Compounded injection from $249. Brand-name care advertises a $149/mo consultation, with medication billed separately.

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability for your address and prescription.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Kin Meds: Compare the compounded offer with the combined consultation and pharmacy costs for branded care.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.